Literature DB >> 4008045

Reactivity of type-specific monoclonal antibodies with Staphylococcus aureus clinical isolates and purified capsular polysaccharide.

M J Nelles, C A Niswander, W W Karakawa, W F Vann, R D Arbeit.   

Abstract

Staphylococcus aureus has been classified into at least eight different capsular types by using polyclonal rabbit antisera specific for their associated capsular polysaccharides. We produced and characterized monoclonal antibodies reactive with two serologically distinct capsular types, types 5 and 8, which account for more than 70% of all S. aureus bacteremias. These type-specific, monoclonal antibodies reacted with S. aureus clinical isolates possessing the homologous capsular type and exhibited no cross-reactivity against S. aureus clinical isolates possessing the heterologous capsular type, nontypeable S. aureus clinical isolates, Staphylococcus epidermidis clinical isolates, or a variety of gram-negative organisms. The anti-type 8 monoclonal antibodies also reacted with purified capsular polysaccharide derived from the prototype type 8 S. aureus strain.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4008045      PMCID: PMC262050          DOI: 10.1128/iai.49.1.14-18.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines.

Authors:  J F Kearney; A Radbruch; B Liesegang; K Rajewsky
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

2.  Characterization of the surface antigens of Staphylococcus aureus, strain K-93M.

Authors:  W W Karakawa; J A Kane
Journal:  J Immunol       Date:  1972-05       Impact factor: 5.422

3.  A capsulate Staphylococcus aureus.

Authors:  A C Scott
Journal:  J Med Microbiol       Date:  1969-08       Impact factor: 2.472

4.  Structural analysis of the cellular constituents of a fresh clinical isolate of Staphylococcus aureus, and their role in the interaction between the organisms and polymorphonuclear leukocytes in the presence of serum factors.

Authors:  W W Karakawa; D A Young; J A Kane
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

5.  Isolation of an acidic surface antigen from a conventional strain of Staphylococcus aureus.

Authors:  W W Karakawa; J A Kane; M R Smith
Journal:  Infect Immun       Date:  1974-03       Impact factor: 3.441

6.  Immunochemical study of diverse surface antigens of a Staphylococcus aureus isolate from an osteomyelitis patient and their role in in vitro phagocytosis.

Authors:  W W Karakawa; D A Young
Journal:  J Clin Microbiol       Date:  1979-03       Impact factor: 5.948

7.  Immunochemical analysis of a Smith-like antigen isolated from two human strains of Staphylococcus aureus.

Authors:  W W Karakawa; J A Kane
Journal:  J Immunol       Date:  1975-08       Impact factor: 5.422

8.  A simple method for polyethylene glycol-promoted hybridization of mouse myeloma cells.

Authors:  M L Gefter; D H Margulies; M D Scharff
Journal:  Somatic Cell Genet       Date:  1977-03

9.  Subclass restriction of murine anti-carbohydrate antibodies.

Authors:  R M Perlmutter; D Hansburg; D E Briles; R A Nicolotti; J M Davie
Journal:  J Immunol       Date:  1978-08       Impact factor: 5.422

10.  The behavior of virulent and avirulent staphylococci in the tissues of normal mice.

Authors:  J M SMITH; R J DUBOS
Journal:  J Exp Med       Date:  1956-01-01       Impact factor: 14.307

View more
  13 in total

1.  A Shared noncapsular antigen is responsible for false-positive reactions by Staphylococcus epidermidis in commercial agglutination tests for Staphylococcus aureus.

Authors:  J E Blake; M A Metcalfe
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

2.  Reactivity of coagulase-negative staphylococci isolated from cow and goat milk with monoclonal antibodies to Staphylococcus aureus capsular polysaccharide types 5 and 8.

Authors:  B Poutrel; C Mendolia; L Sutra; J M Fournier
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

3.  Capsular antibodies induce type-specific phagocytosis of capsulated Staphylococcus aureus by human polymorphonuclear leukocytes.

Authors:  W W Karakawa; A Sutton; R Schneerson; A Karpas; W F Vann
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

4.  Genetic and serologic evaluation of capsule production by bovine mammary isolates of Staphylococcus aureus and other Staphylococcus spp. from Europe and the United States.

Authors:  T Tollersrud; K Kenny; A J Reitz; J C Lee
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

5.  Expression of type 8 capsular polysaccharide and production of toxic shock syndrome toxin 1 are associated among vaginal isolates of Staphylococcus aureus.

Authors:  J C Lee; M J Liu; J Parsonnet; R D Arbeit
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

6.  Virulence of Staphylococcus aureus mutants altered in type 5 capsule production.

Authors:  A Albus; R D Arbeit; J C Lee
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

7.  Phagocytic killing of encapsulated and microencapsulated Staphylococcus aureus by human polymorphonuclear leukocytes.

Authors:  S Xu; R D Arbeit; J C Lee
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

8.  Production and characterization of agglutinating monoclonal antibodies against predominant antigenic factors for Candida albicans.

Authors:  Y Miyakawa; K Kagaya; Y Fukazawa; G Soe
Journal:  J Clin Microbiol       Date:  1986-05       Impact factor: 5.948

9.  Antibodies to capsular polysaccharides are not protective against experimental Staphylococcus aureus endocarditis.

Authors:  J Nemeth; J C Lee
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

10.  Direct testing of blood culture for detection of the serotype 5 and 8 capsular polysaccharides of Staphylococcus aureus.

Authors:  A Boutonnier; F Nato; A Bouvet; L Lebrun; A Audurier; J C Mazie; J M Fournier
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.